Scholarlink

Background <p><i>Streptococcus dysgalactiae</i> subsp. <i>equisimilis</i> (SDSE), historically considered less virulent than <i>Streptococcus pyogenes</i>, has emerged as an important invasive pathogen, particularly in aging societies. Data on nationwide clinical and molecular epidemiology in super-aged populations remain limited. We aimed to identify admission abnormalities associated with the 28-day mortality for invasive SDSE (iSDSE) infections in Japanese adults and evaluate the molecular epidemiology of this emerging pathogen through a large-scale surveillance.</p> Methods <p>A prospective nationwide surveillance of iSDSE was conducted between March 2024 and March 2025 in 132 hospitals across Japan. Clinical, epidemiological, and laboratory data, including <i>emm</i> type distribution, were collected and analyzed.</p> Results <p>Overall, 278 patients with iSDSE infections were identified (median age, 83 years); one-quarter of the patients were residents of long-term care facilities. Nearly all patients had comorbidities. The 28-day mortality was 12.2% overall, which increased to 16.1% among patients aged ≥ 80 years. Fatal outcomes were strongly associated with bacteremic pneumonia and streptococcal toxic shock syndrome, whereas cellulitis showed a lower mortality burden. Intensive care unit admission, mechanical ventilation, and vasopressor use were more common in patients with fatal outcomes, reflecting disease severity. Variables associated with poor outcome included leukopenia, thrombocytopenia, and elevated levels of C-reactive protein, creatinine, and creatine kinase. <i>Emm</i> typing revealed <i>stG</i>6792 as the predominant lineage; however, a marked increase of <i>stG</i>840 was observed. No significant outcome differences were noted across <i>emm</i> types.</p> Conclusions <p>These findings emphasize the combined impact of advanced age, comorbid conditions, and critical illness on iSDSE outcomes, highlight the clinical burden of iSDSE in older adults, and support continued monitoring in Japan.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Invasive Streptococcus dysgalactiae subsp. equisimilis infections in a super-aged society: a Japanese nationwide observational study (2024–2025)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Shigeo Hanada,
  • Misako Takata,
  • Miyuki Morozumi,
  • Kiyofumi Ohkusu,
  • Haruko Miyazaki,
  • Satoshi Iwata,
  • Kimiko Ubukata,
  • Shigeki Nakamura

摘要

Background

Streptococcus dysgalactiae subsp. equisimilis (SDSE), historically considered less virulent than Streptococcus pyogenes, has emerged as an important invasive pathogen, particularly in aging societies. Data on nationwide clinical and molecular epidemiology in super-aged populations remain limited. We aimed to identify admission abnormalities associated with the 28-day mortality for invasive SDSE (iSDSE) infections in Japanese adults and evaluate the molecular epidemiology of this emerging pathogen through a large-scale surveillance.

Methods

A prospective nationwide surveillance of iSDSE was conducted between March 2024 and March 2025 in 132 hospitals across Japan. Clinical, epidemiological, and laboratory data, including emm type distribution, were collected and analyzed.

Results

Overall, 278 patients with iSDSE infections were identified (median age, 83 years); one-quarter of the patients were residents of long-term care facilities. Nearly all patients had comorbidities. The 28-day mortality was 12.2% overall, which increased to 16.1% among patients aged ≥ 80 years. Fatal outcomes were strongly associated with bacteremic pneumonia and streptococcal toxic shock syndrome, whereas cellulitis showed a lower mortality burden. Intensive care unit admission, mechanical ventilation, and vasopressor use were more common in patients with fatal outcomes, reflecting disease severity. Variables associated with poor outcome included leukopenia, thrombocytopenia, and elevated levels of C-reactive protein, creatinine, and creatine kinase. Emm typing revealed stG6792 as the predominant lineage; however, a marked increase of stG840 was observed. No significant outcome differences were noted across emm types.

Conclusions

These findings emphasize the combined impact of advanced age, comorbid conditions, and critical illness on iSDSE outcomes, highlight the clinical burden of iSDSE in older adults, and support continued monitoring in Japan.